Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Angiosarcoma of the scalp is a rare cancer which most commonly affects the elderly. This condition is characterized by bruise-like lesions that escalate to elevated, nodular, or ulcerated tumors. Extensive local growth is common and metastasis to regional lymph nodes and to the lungs may occur. The cause of angiosarcoma of the scalp is unknown, although several associations have been reported, including lymphedema, prior radiation treatment, and environmental exposures. Treatment may include surgery, radiation and chemotherapy.
Biomarker and diagnostic research for angiosarcoma of the scalp has been reported in the published literature.
No clinical trials have been registered for angiosarcoma of the scalp.
20 publications have been identified in PubMed for angiosarcoma of the scalp. Research spans Case Report / Case Series (70%), Review / Meta-Analysis (10%), and Gene Therapy / Novel Therapeutics (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 | 70% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:06 PM UTC
2 |
10% |
New treatment approaches | 2 | 10% |
Testing and diagnosis research | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Nakayama Y (2026). [PMID: 41147059](https://pubmed.ncbi.nlm.nih.gov/41147059/). *The Journal of dermatology*. [Case Report / Case Series]
Jadhav V (2026). [PMID: 40902156](https://pubmed.ncbi.nlm.nih.gov/40902156/). *Clinical nuclear medicine*. [Case Report / Case Series]
Fu X (2026). [PMID: 41517758](https://pubmed.ncbi.nlm.nih.gov/41517758/). *Medicine*. [Case Report / Case Series]
Hojjat C (2026). [PMID: 42246329](https://pubmed.ncbi.nlm.nih.gov/42246329/). *Dermatol Online J*. [Case Report / Case Series]
Ohira A (2025). [PMID: 39822133](https://pubmed.ncbi.nlm.nih.gov/39822133/). *Cancer science*. [Diagnostic / Biomarker]
Murasawa E (2025). [PMID: 39604066](https://pubmed.ncbi.nlm.nih.gov/39604066/). *Geriatrics & gerontology international*. [Case Report / Case Series]
Chen TW (2025). [PMID: 40056281](https://pubmed.ncbi.nlm.nih.gov/40056281/). *Current treatment options in oncology*. [Review / Meta-Analysis]
Cristescu AN (2025). [PMID: 40004808](https://pubmed.ncbi.nlm.nih.gov/40004808/). *Journal of clinical medicine*. [Gene Therapy / Novel Therapeutics]
Rausch M (2025). [PMID: 39936863](https://pubmed.ncbi.nlm.nih.gov/39936863/). *The journal of international advanced otology*. [Case Report / Case Series]
Mandli S (2025). [PMID: 40688163](https://pubmed.ncbi.nlm.nih.gov/40688163/). *Indian dermatology online journal*. [Case Report / Case Series]